Skip to menu Skip to content Skip to footer

Development of an advanced Hepatitis B nanovaccine for human use - Stage 1 (2015)

Experts

Professor Michael Yu

Professorial Research Fellow & SGL
Australian Institute for Bioengineering and Nanotechnology
Michael Yu
Michael Yu